Finance News – Merck
What is your interest today?
Bitcoin
Crypto
Btc
Ceo
Tariffs
Stocks
Crypto Assets
Cryptocurrency
Investors
Stock
Shares
Stock Market
Ethereum
Price
Markets
Xrp
Investment
Blockchain
Sec
Etf
Stablecoin
Eth
Trade
Earnings
Solana
Index
Bse
Revenue
Ipo
China
Coinbase
Token
Wall Street
Nasdaq
Inflation
Interest Rates
Trade War
Usd
Economy
Sensex
Tesla
Profit
Digital Assets
Traders
Nse
Sp 500
Gold
Treasury
Federal Reserve
Nvidia
Chainlink
Debit Card
Changpeng Cz
Transportation Costs
Uk Retail Sales
Dragons Den
Bci
Japanese 30 Year Bonds
Swyftx
Section 899
Filter by:
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
CNBC Business • Jun 09, 2025
FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca
Merck’s newly authorized RSV vaccine for infants is expected to impact the market by challenging established treatments, potentially influencing sales and market share among leadin...
Read Full Article →